Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook - Seite 3

Orion continues persistent actions to generate growth. Due to the estimated sales development and these actions the operating profit excluding material capital gains is estimated to be lower than in 2017 (operating profit excluding capital gains was EUR 293 million in 2017).

Orion Corporation

Timo Lappalainen  President and CEO

Olli Huotari SVP, Corporate Functions

                                               
Contact person:
Jari Karlson, CFO,  Orion Corporation
tel. [phone]

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orion.fi/en

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs. Orion's adjusted net sales in 2017 amounted to EUR 1,034 million and the company had about 3,200 employees. Orion's A and B shares are listed on Nasdaq Helsinki.

Founded in 1994 by a group of Denmark's largest financial and industrial institutions, Axcel Management is a pan-Nordic private equity firm focusing on mid-market companies and has a broad base of both Nordic and international investors. Axcel has raised five funds with total committed capital of around EUR 2 billion to date. These funds have made 50 platform investments, approximately 100 major add-on investments and 39 exits. Axcel currently owns eleven companies with combined annual revenue of around EUR 1.4 billion and some 6,300 employees.

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Orion Oyj via Globenewswire